Apricot Capital describes its mission as connecting China's biotech ecosystem to the global healthcare landscape, pointing to more than 20 licensing deals with companies like Johnson & Johnson, AstraZeneca, BioNTech, Roche, and Novartis worth a combined $45 billion, and it backs this with a team of 20+ investment professionals from clinical, pharmaceutical, and healthcare operations backgrounds, over 300 advisors, and senior leaders like former top-ranked healthcare analyst Arthur Qiang and hospital-management veteran William Mao. Founder Crystal Liu has raised six funds, led investments in nearly 70 life science ventures, holds a doctorate in public health from Johns Hopkins, and has published close to 20 research papers along with a 2024 book on hospital management, while the firm has occasionally invested outside pure healthcare, such as backing Singapore's Geniebook.
Investors AT THE FUND
Notable Investments
What Makes them Unique
Press & Media
No items found.
Sheets They're In
No items found.
Is this information out of date? Let us know
Popular fUNDS
Fund name
Active in
Rounds
Avg. Check
Links
.svg)
Or automatically find your investor matches
Upload your pitch deck to get your best investor matches in minutes.
Reveal the very best VCs to pitch for your startup
Get matching investors' email addresses
No ads. No catch. Free from VC Sheet.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Success. Check your email in 5 minutes.
.jpeg){kind=logo}
.png)
.jpeg)
.jpeg)
